175 related articles for article (PubMed ID: 32534178)
1. Increased IL-8 levels in HIV-infected individuals who initiated ART with CD4
Ellwanger JH; Valverde-Villegas JM; Kaminski VL; de Medeiros RM; Almeida SEM; Santos BR; de Melo MG; Hackenhaar FS; Chies JAB
Microbes Infect; 2020 Oct; 22(9):474-480. PubMed ID: 32534178
[TBL] [Abstract][Full Text] [Related]
2. Plasma Levels of Secreted Cytokines in Virologically Controlled HIV-Infected Aging Adult Individuals on Long-Term Antiretroviral Therapy.
Love M; Behrens-Bradley N; Ahmad A; Wertheimer A; Klotz S; Ahmad N
Viral Immunol; 2024 May; 37(4):202-215. PubMed ID: 38717822
[TBL] [Abstract][Full Text] [Related]
3. Acute plasma biomarkers of T cell activation set-point levels and of disease progression in HIV-1 infection.
Liovat AS; Rey-Cuillé MA; Lécuroux C; Jacquelin B; Girault I; Petitjean G; Zitoun Y; Venet A; Barré-Sinoussi F; Lebon P; Meyer L; Sinet M; Müller-Trutwin M
PLoS One; 2012; 7(10):e46143. PubMed ID: 23056251
[TBL] [Abstract][Full Text] [Related]
4. Plasma concentrations of transforming growth factor beta 1 in non-progressive HIV-1 infection correlates with markers of disease progression.
Maina EK; Abana CZ; Bukusi EA; Sedegah M; Lartey M; Ampofo WK
Cytokine; 2016 May; 81():109-16. PubMed ID: 26986868
[TBL] [Abstract][Full Text] [Related]
5. IL-8 Alterations in HIV-1 Infected Children With Disease Progression.
Pananghat AN; Aggarwal H; Prakash SS; Makhdoomi MA; Singh R; Lodha R; Ali S; Srinivas M; Das BK; Pandey RM; Kabra SK; Luthra K
Medicine (Baltimore); 2016 May; 95(21):e3734. PubMed ID: 27227934
[TBL] [Abstract][Full Text] [Related]
6. High CXCL10/IP-10 levels are a hallmark in the clinical evolution of the HIV infection.
Valverde-Villegas JM; de Medeiros RM; Ellwanger JH; Santos BR; Melo MG; Almeida SEM; Chies JAB
Infect Genet Evol; 2018 Jan; 57():51-58. PubMed ID: 29122683
[TBL] [Abstract][Full Text] [Related]
7. Reduction of inflammation and T cell activation after 6 months of cART initiation during acute, but not in early chronic HIV-1 infection.
de Paula HHS; Ferreira ACG; Caetano DG; Delatorre E; Teixeira SLM; Coelho LE; João EG; de Andrade MM; Cardoso SW; Grinsztejn B; Veloso VG; Morgado MG; Guimarães ML; Côrtes FH
Retrovirology; 2018 Dec; 15(1):76. PubMed ID: 30541557
[TBL] [Abstract][Full Text] [Related]
8. Plasma Cytokine Levels in Chronic Asymptomatic HIV-1 Subtype C Infection as an Indicator of Disease Progression in Botswana: A Retrospective Case Control Study.
Iketleng T; Moyo S; Gaseitsiwe S; Nyombi B; Mitchell RM; Makhema J; Baum MK; Marlink R; Essex M; Musonda R
AIDS Res Hum Retroviruses; 2016 Apr; 32(4):364-9. PubMed ID: 26414751
[TBL] [Abstract][Full Text] [Related]
9. Baseline Inflammatory Biomarkers Identify Subgroups of HIV-Infected African Children With Differing Responses to Antiretroviral Therapy.
Prendergast AJ; Szubert AJ; Berejena C; Pimundu G; Pala P; Shonhai A; Musiime V; Bwakura-Dangarembizi M; Poulsom H; Hunter P; Musoke P; Kihembo M; Munderi P; Gibb DM; Spyer M; Walker AS; Klein N;
J Infect Dis; 2016 Jul; 214(2):226-36. PubMed ID: 27190179
[TBL] [Abstract][Full Text] [Related]
10. Impact of ART on dynamics of growth factors and cytokines in primary HIV infection.
Bordoni V; Sacchi A; Casetti R; Cimini E; Tartaglia E; Pinnetti C; Mondi A; Gruber CEM; Antinori A; Agrati C
Cytokine; 2020 Jan; 125():154839. PubMed ID: 31542514
[TBL] [Abstract][Full Text] [Related]
11. Daily low-dose subcutaneous interleukin-2 added to single- or dual-nucleoside therapy in HIV infection does not protect against CD4+ T-cell decline or improve other indices of immune function: results of a randomized controlled clinical trial (ACTG 248).
Vogler MA; Teppler H; Gelman R; Valentine F; Lederman MM; Pomerantz RJ; Pollard RB; Cherng DW; Gonzalez CJ; Squires KE; Frank I; Mildvan D; Mahon LF; Schock B;
J Acquir Immune Defic Syndr; 2004 May; 36(1):576-87. PubMed ID: 15097300
[TBL] [Abstract][Full Text] [Related]
12. Clinical characteristics of HIV-1-infected patients with high levels of plasma interferon-γ: a multicenter observational study.
Watanabe D; Uehira T; Suzuki S; Matsumoto E; Ueji T; Hirota K; Minami R; Takahama S; Hayashi K; Sawamura M; Yamamoto M; Shirasaka T
BMC Infect Dis; 2019 Jan; 19(1):11. PubMed ID: 30611204
[TBL] [Abstract][Full Text] [Related]
13. Increased Plasma Levels of the TH2 chemokine CCL18 associated with low CD4+ T cell counts in HIV-1-infected Patients with a Suppressed Viral Load.
Malhotra P; Haslett P; Sherry B; Shepp DH; Barber P; Abshier J; Roy U; Schmidtmayerova H
Sci Rep; 2019 Apr; 9(1):5963. PubMed ID: 30979916
[TBL] [Abstract][Full Text] [Related]
14. Impaired Th17 polarization of phenotypically naive CD4(+) T-cells during chronic HIV-1 infection and potential restoration with early ART.
DaFonseca S; Niessl J; Pouvreau S; Wacleche VS; Gosselin A; Cleret-Buhot A; Bernard N; Tremblay C; Jenabian MA; Routy JP; Ancuta P
Retrovirology; 2015 Apr; 12():38. PubMed ID: 25924895
[TBL] [Abstract][Full Text] [Related]
15. Safety and immunogenicity of an adjuvanted protein therapeutic HIV-1 vaccine in subjects with HIV-1 infection: a randomised placebo-controlled study.
Harrer T; Plettenberg A; Arastéh K; Van Lunzen J; Fätkenheuer G; Jaeger H; Janssens M; Burny W; Collard A; Roman F; Loeliger A; Koutsoukos M; Bourguignon P; Lavreys L; Voss G
Vaccine; 2014 May; 32(22):2657-65. PubMed ID: 24144472
[TBL] [Abstract][Full Text] [Related]
16. Inflammatory profile of vertically HIV-1 infected adolescents receiving ART in Cameroon: a contribution toward optimal pediatric HIV control strategies.
Ka'e AC; Nanfack AJ; Ambada G; Santoro MM; Takou D; Semengue ENJ; Nka AD; Bala MLM; Endougou ON; Elong E; Beloumou G; Djupsa S; Gouissi DH; Fainguem N; Tchouaket MCT; Sosso SM; Kesseng D; Ndongo FA; Sonela N; Kamta ACL; Tchidjou HK; Ndomgue T; Ndiang STM; Nlend AEN; Nkenfou CN; Montesano C; Halle-Ekane GE; Cappelli G; Tiemessen CT; Colizzi V; Ceccherini-Silberstein F; Perno CF; Fokam J
Front Immunol; 2023; 14():1239877. PubMed ID: 37646023
[TBL] [Abstract][Full Text] [Related]
17. Rapid and Slow Progressors Show Increased IL-6 and IL-10 Levels in the Pre-AIDS Stage of HIV Infection.
de Medeiros RM; Valverde-Villegas JM; Junqueira DM; Gräf T; Lindenau JD; de Mello MG; Vianna P; Almeida SE; Chies JA
PLoS One; 2016; 11(5):e0156163. PubMed ID: 27214135
[TBL] [Abstract][Full Text] [Related]
18. CXCL13 as a Biomarker of Immune Activation During Early and Chronic HIV Infection.
Mehraj V; Ramendra R; Isnard S; Dupuy FP; Lebouché B; Costiniuk C; Thomas R; Szabo J; Baril JG; Trottier B; Coté P; LeBlanc R; Durand M; Chartrand-Lefebvre C; Kema I; Zhang Y; Finkelman M; Tremblay C; Routy JP
Front Immunol; 2019; 10():289. PubMed ID: 30846990
[No Abstract] [Full Text] [Related]
19. Biological determinants of immune reconstitution in HIV-infected patients receiving antiretroviral therapy: the role of interleukin 7 and interleukin 7 receptor α and microbial translocation.
Rajasuriar R; Booth D; Solomon A; Chua K; Spelman T; Gouillou M; Schlub TE; Davenport M; Crowe S; Elliott J; Hoy J; Fairley C; Stewart G; Cameron P; Lewin SR
J Infect Dis; 2010 Oct; 202(8):1254-64. PubMed ID: 20812848
[TBL] [Abstract][Full Text] [Related]
20. Dysfunctional phenotypes of CD4+ and CD8+ T cells are comparable in patients initiating ART during early or chronic HIV-1 infection.
Amu S; Lantto Graham R; Bekele Y; Nasi A; Bengtsson C; Rethi B; Sorial S; Meini G; Zazzi M; Hejdeman B; Chiodi F
Medicine (Baltimore); 2016 Jun; 95(23):e3738. PubMed ID: 27281071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
